High Dose Inhaled Mannitol Study

Summary

High Dose Inhaled Mannitol Study is a clinical trial^[1].

Key Facts

• High Dose Inhaled Mannitol Study is in the country of Australia^[2].
• High Dose Inhaled Mannitol Study's instance of is recorded as clinical trial^[3].
• High Dose Inhaled Mannitol Study's start time is recorded as +2009-01-31T00:00:00Z^[4].
• High Dose Inhaled Mannitol Study's end time is recorded as +2009-03-31T00:00:00Z^[5].
• High Dose Inhaled Mannitol Study's sponsor is recorded as Pharmaxis (United Kingdom)^[6].
• High Dose Inhaled Mannitol Study's main subject is recorded as bronchiectasis^[7].
• High Dose Inhaled Mannitol Study's number of participants is recorded as {'unit': '1', 'amount': '+10'}^[8].
• High Dose Inhaled Mannitol Study's title is recorded as A Pilot Study to Investigate the Feasibility and Tolerability of Inhaling a High Dose of Dry Powder Mannitol (IDPM) Per Breath Administered Via a Dry Powder Inhaler Loaded With a Single Capsule in Subjects With Bronchiectasis^[9].
• High Dose Inhaled Mannitol Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• High Dose Inhaled Mannitol Study's ClinicalTrials.gov ID is recorded as NCT01076491^[11].
• High Dose Inhaled Mannitol Study's research intervention is recorded as D-(-)-mannitol^[12].
• High Dose Inhaled Mannitol Study's clinical trial phase is recorded as phase I clinical trial^[13].
• High Dose Inhaled Mannitol Study's clinical trial phase is recorded as phase II clinical trial^[14].
• High Dose Inhaled Mannitol Study's research site is recorded as Royal Prince Alfred Hospital^[15].
• High Dose Inhaled Mannitol Study's research subject recruitment status is recorded as completed^[16].
• High Dose Inhaled Mannitol Study's research subject recruitment status is recorded as completed^[17].
• High Dose Inhaled Mannitol Study's study type is recorded as interventional study^[18].